Kimberly-Clark (NYSE: KMB) reported Q4 EPS of $1.51, $0.03 worse than the analyst estimate of $1.54. Revenue for the quarter came in at $5 billion versus the consensus estimate of $4.99 billion.

OUTLOOK

The company currently expects to deliver a low-to-mid single digit percentage increase in 2024 Organic Net Sales versus the prior year period, with growth in reported Net Sales forecast to reflect negative impacts of approximately 300 basis points from currency translation and 60 basis points from the Brazil Tissue divestiture. Adjusted Operating Profit is expected to grow at a high single-digit to low double-digit rate on a constant-currency basis and Adjusted Earnings Per share are expected to grow at a high single-digit rate on a constant-currency basis versus the prior year period. Reported growth in Operating Profit and Earnings Per Share are currently expected to be negatively impacted by approximately 400 basis points from currency translation.

For earnings history and earnings-related data on Kimberly-Clark (KMB) click here.